Scientific Highlights of the 3rd Fraunhofer Life Science Symposium
Only few weeks until the start of the 3rd Fraunhofer Life Science Symposium in Leipzig. On October 24 and 25, 2008 researchers and industrial partners will meet in Leipzig to discuss their latest findings in the fields of ischemia and regeneration.
Speakers from Germany, France, USA and Israel will present their findings. A major theme is the role of stem cell therapy in ischemic diseases. Two sessions address this cutting-edge issue. Keynote lectures come from Prof. Bodo Eckehard-Strauer who will speak about the potential of bone marrow cells as a therapy for heart failure.
Prof. Jürgen Hescheler will as well focus on cardiac stem cell therapy especially in regards to clinical indication for cell therapy and long term outcomes. In addition to cardiac ischemia, cerebral ischemia is a serious and widespread disease in industrial nations. Dr. Brigitte Onteniente from Paris will give a lecture about the potential of human embryonic stem cells in stroke.
Altogether, the two days offer 24 high-level lectures in 6 sessions, over 30 scientific posters as well as 17 industrial exhibitors in the new and modern building of the Fraunhofer Institute for Cell Therapy and Immunology in Leipzig.
The complete programme and the registration form are available under http://www.fs-leipzig.com.
Media Contact
All latest news from the category: Event News
Newest articles
Trotting robots reveal emergence of animal gait transitions
A four-legged robot trained with machine learning by EPFL researchers has learned to avoid falls by spontaneously switching between walking, trotting, and pronking – a milestone for roboticists as well…
Innovation promises to prevent power pole-top fires
Engineers in Australia have found a new way to make power-pole insulators resistant to fire and electrical sparking, promising to prevent dangerous pole-top fires and reduce blackouts. Pole-top fires pose…
Possible alternative to antibiotics produced by bacteria
Antibacterial substance from staphylococci discovered with new mechanism of action against natural competitors. Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers…
